Previous close | 130.30 |
Open | 130.00 |
Bid | 159.00 |
Ask | 169.00 |
Strike | 165.00 |
Expiry date | 2025-01-17 |
Day's range | 130.00 - 130.30 |
Contract range | N/A |
Volume | |
Open interest | 11 |
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.